CRISPR

CRISPR5-il6

ID
ZDB-CRISPR-241007-1
Name
CRISPR5-il6
Previous Names
None
Target
Sequence
5' - GGCAGCGGTCTGAAGGTTTG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf4118 il6
Expression
Gene expression in Wild Types + CRISPR5-il6
No data available
Phenotype
Phenotype resulting from CRISPR5-il6
No data available
Phenotype of all Fish created by or utilizing CRISPR5-il6
Phenotype Fish Conditions Figures
liver tmco1 expression increased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver ctnnb2 expression decreased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver apoeb expression decreased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver malonaldehyde amount, ameliorated il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 5 with image from Zhai et al., 2023
liver dpm3 expression increased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver aldh1l1 expression decreased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver L-alanine:2-oxoglutarate aminotransferase activity process quality, ameliorated il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 2 with imageFigure 7 with image from Zhai et al., 2023
liver aclya expression increased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver L-aspartate:2-oxoglutarate aminotransferase activity process quality, ameliorated il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 2 with imageFigure 7 with image from Zhai et al., 2023
liver damage, ameliorated il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 2 with image from Zhai et al., 2023
liver lrpap1 expression increased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver superoxide dismutase activity process quality, ameliorated il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 5 with image from Zhai et al., 2023
liver cyp51 expression increased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver dazap2 expression decreased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver abcc2 expression decreased amount, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 3 with image from Zhai et al., 2023
liver reactive oxygen species amount, ameliorated il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 5 with image from Zhai et al., 2023
liver nucleate erythrocyte infiltrative, abnormal il6zf4118/zf4118 (AB) bacterial treatment by injection: Aeromonas hydrophila Figure 2 with image from Zhai et al., 2023
Citations